FDA Adverse Event Malfunction Summary report: N

CMV IGG, IGG ANTIBODIES TO CYTOMEGALOVIRUS

MDR report key: 7855712 · Received September 7, 2018

Report

Report Number
1823260-2018-03029
Event Type
Malfunction
Date Received
September 7, 2018
Date of Event
March 7, 2018
Report Date
November 12, 2018
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFZ
UDI-DI
04015630923489
PMA / PMN Number
K131605
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

SAMPLES FROM BOTH PATIENTS WERE SUBMITTED FOR INVESTIGATION WHERE THE SAMPLES WERE REACTIVE WHEN TESTED ON THE RECOMLINE CMV IGM AND THE RECOMLINE CMV IGG ASSAY. ALL SAMPLES FROM THE PATIENTS SHOWED ELEVATED IGG SIGNALS SUPPORTING THE SUSPICION OF A PRIMARY CMV INFECTION. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED. PRODUCT LABELING STATES FALSE NEGATIVE RESULTS MAY OCCUR FOR CMV IGG. THE INVESTIGATION DETERMINED THE CMV IGG ASSAY PERFORMS WITHIN SPECIFICATION.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER QUESTIONED RESULTS FOR 4 PATIENT SAMPLES TESTED FOR ELECSYS CMV IGG ASSAY (CMV IGG) AND ELECSYS CMV IGM IMMUNOASSAY (CMV IGM) ON A COBAS 6000 C (501) MODULE COMPARED TO OTHER METHODS. BASED ON THE DATA PROVIDED, THE RESULTS FOR 1 PATIENT WERE DISCREPANT FOR CMV IGG AND CMV IGM AND THE RESULTS FOR 1 PATIENT WERE DISCREPANT FOR CMV IGG. THIS MEDWATCH WILL COVER CMV IGG. REFER TO MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE CMV IGM RESULTS. THE INCORRECT RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THERE WAS NO ALLEGATION THAT AN ADVERSE EVENT OCCURRED. THE C501 MODULE SERIAL NUMBER WAS (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
696791 CMV IGG, IGG ANTIBODIES TO CYTOMEGALOVIRUS ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS LFZ ROCHE DIAGNOSTICS NA ASKU 04015630923489

Patients

Seq Age Sex Outcome Treatment
1